Ralph Charlton

Technik-/Wissenschafts-/F&E-Leiter bei SPRUCE BIOSCIENCES, INC.

Vermögen: 38 816 $ am 30.04.2024

54 Jahre

Health Technology

Consumer Services

Aktive Positionen von Ralph Charlton

Unternehmen	Position	Beginn	Ende
SPRUCE BIOSCIENCES, INC.	Technik-/Wissenschafts-/F&E-Leiter	14.03.2022	-

Unternehmen	Position	Beginn	Ende
89BIO, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.11.2020	01.02.2022
Ascendis Pharma, Inc.	Technik-/Wissenschafts-/F&E-Leiter	01.05.2019	01.11.2020
ALLERGAN, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.07.2018	01.05.2019

University of Southern California

Doctorate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	4
Doctorate Degree	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
SPRUCE BIOSCIENCES, INC.	Health Technology
89BIO, INC.	Health Technology

Private Unternehmen	2
Ascendis Pharma, Inc.
Allergan, Inc. Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA.	Health Technology

Private Unternehmen

Ascendis Pharma, Inc.

Health Technology